[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.141.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
October 13, 2004

Intrathecal Ziconotide for Chronic Pain

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2004;292(14):1681-1682. doi:10.1001/jama.292.14.1681-b

To the Editor: Dr Staats and colleagues1 reported that intrathecal ziconotide was effective at relieving pain among patients with cancer or human immunodeficiency virus (HIV). We have several concerns about this study.

First, pain among patients with cancer may have several different etiologies that may be related to the stage of the disease. Patients with end-stage disease may not represent all patients with cancer, some of whom may experience severe pain early in their disease.

First Page Preview View Large
First page PDF preview
First page PDF preview
×